Press Release: Basilea launches the placement of -2-
Werte in diesem Artikel
NOT BE PUBLICLY OFFERED OR SOLD IN THE UNITED STATES.
This communication does not constitute an "offer of securities to the
public" within the meaning of Regulation 2017/1129 of the European Union
(the "Prospectus Regulation") of the securities referred to in it (the
"Securities") in any member state of the European Economic Area (the
"EEA"). Any offers of the Securities to persons in the EEA will be made
pursuant to an exemption under the Prospectus Regulation, as implemented
in member states of the EEA, from the requirement to produce a
prospectus for offers of the Securities.
This communication expressly or implicitly contains certain
forward-looking statements concerning the Company and its business. Such
statements involve certain known and unknown risks, uncertainties and
other factors, which could cause the actual results, financial condition,
performance or achievements of the Company to be materially different
from any future results, performance or achievements expressed or
implied by such forward-looking statements. The Company is providing
this communication as of this date and does not undertake to update any
forward-looking statements contained herein as a result of new
information, future events or otherwise.
For further information, please contact:
Peer Nils Schröder, PhD
Head of Corporate Communications & Investor Relations
Phone +41 61 606 1102
E-mail media_relations@basilea.com
investor_relations@basilea.com
This press release can be downloaded from www.basilea.com.
Attachment
-- Press release (PDF)
https://ml-eu.globenewswire.com/Resource/Download/cb6b6666-3513-40d6-8e54-3ff7539fb523
(END) Dow Jones Newswires
June 24, 2020 01:15 ET (05:15 GMT)
Ausgewählte Hebelprodukte auf Basilea Pharmaceutica
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Basilea Pharmaceutica
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Basilea Pharmaceutica Aktie News
Basilea Pharmaceutica Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Basilea Pharmaceutica nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.02.13 | Basilea Pharmaceutica halten | Vontobel Research | |
| 07.02.13 | Basilea Pharmaceutica halten | Vontobel Research | |
| 10.12.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 10.12.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 22.11.12 | Basilea Pharmaceutica hold | Vontobel Research |